Showing results (21-30 of 79) with videos related to
Sort By:
Pageof 8
Revue Medicale De Liege|December 29, 2006
[Clinical case of the month: clostridium difficile colitis]V Laret, C Sion, C Bataille, et al.Cancer Biotherapy & Radiopharmaceuticals|October 18, 2001
Positron emission tomography (PET) for staging low-grade non-Hodgkin's lymphomas (NHL)F Najjar, R Hustinx, G Jerusalem, et al.European Journal of Nuclear Medicine|November 7, 1999
Can the standardized uptake value characterize primary brain tumors on FDG-PET?R Hustinx, R J Smith, F Benard, et al.Nuclear Medicine Communications|September 26, 2003
Whole-body positron emission tomography using fluorodeoxyglucose in patients with metastases of unknown primary tumours (CUP syndrome)J L Alberini, T Belhocine, R Hustinx, et al.Acta Clinica Belgica|December 7, 2010
Chorea associated with anti-phospholipid antibodies: case reportJ Demonty, M Gonce, P Ribai, et al.Revue Medicale De Liege|April 19, 2000
[18FDG-PET imaging of pancreatic adenocarcinoma]F Daenen, R Hustinx, T Belhocine, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 24, 1998
Clinical evaluation of whole-body 18F-fluorodeoxyglucose positron emission tomography in the detection of liver metastasesR Hustinx, P Paulus, N Jacquet, et al.European Journal of Nuclear Medicine|February 1, 1996
Staging of non-small-cell lung cancer by whole-body fluorine-18 deoxyglucose positron emission tomographyT Bury, A Dowlati, P Paulus, et al.Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 19, 2008
[Intraoperative scintigraphic visualization of a single rib metastasis from operated prostatic adenocarcinoma]S Sanjurjo, W Hamida, G Letesson, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 18, 1999
Clinical evaluation of processing techniques for attenuation correction with 137Cs in whole-body PET imagingF Bénard, R J Smith, R Hustinx, et al.Pageof 8